Calamos Advisors
AEHR icon

Calamos Advisors’s Aehr Test Systems AEHR Stock Holding History

Calamos Advisors’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,387
Closed -$229K – 1134
2022
Q4 		$229K Buy
+11,387
New +$244K ﹤0.01% 947
2022
Q1 		– Sell
-79,699
Closed -$1.93M – 1155
2021
Q4 		$1.93M Buy
+79,699
New +$1.56M 0.01% 914

Other funds holding AEHR

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Calamos Advisors's AEHR Position: Q1 2023 in Review

Calamos Advisors sold out of Aehr Test Systems (AEHR) in Q1 2023, closing a stake of 11,387 shares — an estimated $229K sold.

Calamos Advisors first reported a position in AEHR in Q4 2021 and held it in 2 quarters. The position peaked at $1.93M in Q4 2021. 144 funds tracked by Wall St. Rank hold AEHR as of Q1 2023.

  • Calamos Advisors reported no remaining Aehr Test Systems position as of Q1 2023 after selling out during the quarter.
  • Calamos Advisors sold 11,387 Aehr Test Systems shares in Q1 2023, an estimated $229K.
  • Calamos Advisors first reported a position in Aehr Test Systems in Q4 2021 and held it in 2 quarters.
  • Calamos Advisors's Aehr Test Systems position peaked at $1.93M in Q4 2021.
  • 144 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2023.

Based on Calamos Advisors's 13F filing for Q1 2023, filed 4 May 2023.